Xenetic Biosciences, Inc. (XBIO) News https://ir.xeneticbio.com/section-16-filings/rss Xenetic Biosciences, Inc. (XBIO) - Section 16 Filings en-us Equisolve Investor Relations Suite https://d1io3yog0oux5.cloudfront.net/xeneticbio/files/theme/images/logo-sm.png https://www.xeneticbio.com <![CDATA[ 8-K - Current report ]]> 8-K, EX-99.1 ]]> https://ir.xeneticbio.com/section-16-filings?page=1#document-3747-0001683168-26-001744 Fri, 13 Mar 26 08:00:52 -0400 https://ir.xeneticbio.com/section-16-filings?page=1#document-3747-0001683168-26-001744 <![CDATA[ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] ]]> 10-K, EX-10.23, EX-10.25, EX-21.1, EX-23.1, EX-23.2, EX-31.1, EX-31.2, EX-32.1 ]]> https://ir.xeneticbio.com/section-16-filings?page=1#document-3745-0001683168-26-001737 Thu, 12 Mar 26 17:01:45 -0400 https://ir.xeneticbio.com/section-16-filings?page=1#document-3745-0001683168-26-001737 <![CDATA[ SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors ]]> https://ir.xeneticbio.com/section-16-filings?page=1#document-3736-0001037389-26-000022 Thu, 12 Feb 26 14:15:57 -0500 https://ir.xeneticbio.com/section-16-filings?page=1#document-3736-0001037389-26-000022 <![CDATA[ 8-K - Current report ]]> https://ir.xeneticbio.com/section-16-filings?page=1#document-3735-0001683168-26-000196 Fri, 09 Jan 26 17:01:13 -0500 https://ir.xeneticbio.com/section-16-filings?page=1#document-3735-0001683168-26-000196 <![CDATA[ 4 - Statement of changes in beneficial ownership of securities ]]> https://ir.xeneticbio.com/section-16-filings?page=1#document-3734-0001683168-26-000101 Mon, 05 Jan 26 17:00:52 -0500 https://ir.xeneticbio.com/section-16-filings?page=1#document-3734-0001683168-26-000101 <![CDATA[ 4 - Statement of changes in beneficial ownership of securities ]]> https://ir.xeneticbio.com/section-16-filings?page=1#document-3733-0001683168-26-000102 Mon, 05 Jan 26 17:00:47 -0500 https://ir.xeneticbio.com/section-16-filings?page=1#document-3733-0001683168-26-000102 <![CDATA[ 4 - Statement of changes in beneficial ownership of securities ]]> https://ir.xeneticbio.com/section-16-filings?page=1#document-3732-0001683168-26-000103 Mon, 05 Jan 26 17:00:40 -0500 https://ir.xeneticbio.com/section-16-filings?page=1#document-3732-0001683168-26-000103 <![CDATA[ 4 - Statement of changes in beneficial ownership of securities ]]> https://ir.xeneticbio.com/section-16-filings?page=1#document-3731-0001683168-26-000104 Mon, 05 Jan 26 17:00:35 -0500 https://ir.xeneticbio.com/section-16-filings?page=1#document-3731-0001683168-26-000104 <![CDATA[ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material ]]> https://ir.xeneticbio.com/section-16-filings?page=1#document-3730-0001683168-25-009077 Thu, 11 Dec 25 17:02:08 -0500 https://ir.xeneticbio.com/section-16-filings?page=1#document-3730-0001683168-25-009077 <![CDATA[ 8-K - Current report ]]> 8-K, EX-99.1 ]]> https://ir.xeneticbio.com/section-16-filings?page=1#document-3729-0001683168-25-009076 Thu, 11 Dec 25 17:01:15 -0500 https://ir.xeneticbio.com/section-16-filings?page=1#document-3729-0001683168-25-009076 <![CDATA[ 8-K - Current report ]]> 8-K, EX-99.1 ]]> https://ir.xeneticbio.com/section-16-filings?page=2#document-3727-0001683168-25-008288 Thu, 13 Nov 25 08:45:49 -0500 https://ir.xeneticbio.com/section-16-filings?page=2#document-3727-0001683168-25-008288 <![CDATA[ 10-Q - Quarterly report [Sections 13 or 15(d)] ]]> 10-Q, EX-31.1, EX-31.2, EX-32.1 ]]> https://ir.xeneticbio.com/section-16-filings?page=2#document-3725-0001683168-25-008259 Wed, 12 Nov 25 16:43:43 -0500 https://ir.xeneticbio.com/section-16-filings?page=2#document-3725-0001683168-25-008259 <![CDATA[ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material ]]> https://ir.xeneticbio.com/section-16-filings?page=2#document-3720-0001683168-25-007873 Fri, 31 Oct 25 16:20:30 -0400 https://ir.xeneticbio.com/section-16-filings?page=2#document-3720-0001683168-25-007873 <![CDATA[ DEF 14A - Definitive proxy statements ]]> https://ir.xeneticbio.com/section-16-filings?page=2#document-3719-0001683168-25-007872 Fri, 31 Oct 25 16:11:03 -0400 https://ir.xeneticbio.com/section-16-filings?page=2#document-3719-0001683168-25-007872 <![CDATA[ ARS - Annual Report to Security Holders ]]> https://ir.xeneticbio.com/section-16-filings?page=2#document-3721-0001683168-25-007876 Fri, 31 Oct 25 16:30:32 -0400 https://ir.xeneticbio.com/section-16-filings?page=2#document-3721-0001683168-25-007876 <![CDATA[ 424B5 - Prospectus [Rule 424(b)(5)] ]]> https://ir.xeneticbio.com/section-16-filings?page=2#document-3714-0001683168-25-007512 Tue, 14 Oct 25 06:02:08 -0400 https://ir.xeneticbio.com/section-16-filings?page=2#document-3714-0001683168-25-007512 <![CDATA[ 8-K - Current report ]]> 8-K, EX-1.1, EX-5.1, EX-99.1 ]]> https://ir.xeneticbio.com/section-16-filings?page=2#document-3718-0001683168-25-007528 Tue, 14 Oct 25 08:49:25 -0400 https://ir.xeneticbio.com/section-16-filings?page=2#document-3718-0001683168-25-007528 <![CDATA[ 424B5 - Prospectus [Rule 424(b)(5)] ]]> https://ir.xeneticbio.com/section-16-filings?page=2#document-3713-0001683168-25-007488 Fri, 10 Oct 25 09:28:44 -0400 https://ir.xeneticbio.com/section-16-filings?page=2#document-3713-0001683168-25-007488 <![CDATA[ 8-K - Current report ]]> 8-K, EX-99.1 ]]> https://ir.xeneticbio.com/section-16-filings?page=2#document-3712-0001683168-25-006001 Wed, 13 Aug 25 08:01:07 -0400 https://ir.xeneticbio.com/section-16-filings?page=2#document-3712-0001683168-25-006001 <![CDATA[ 10-Q - Quarterly report [Sections 13 or 15(d)] ]]> 10-Q, EX-10.1, EX-31.1, EX-31.2, EX-32.1 ]]> https://ir.xeneticbio.com/section-16-filings?page=2#document-3710-0001683168-25-005983 Tue, 12 Aug 25 17:01:23 -0400 https://ir.xeneticbio.com/section-16-filings?page=2#document-3710-0001683168-25-005983